OP1 Coronary artery disease and atherosclerotic plaque subtypes in patients with suspected angina and a coronary calcium score of zero. (7th September 2020)
- Record Type:
- Journal Article
- Title:
- OP1 Coronary artery disease and atherosclerotic plaque subtypes in patients with suspected angina and a coronary calcium score of zero. (7th September 2020)
- Main Title:
- OP1 Coronary artery disease and atherosclerotic plaque subtypes in patients with suspected angina and a coronary calcium score of zero
- Authors:
- Osborne-Grinter, Maia
Kwiecinski, Jacek
Doris, Mhairi
McElhinney, Priscilla
Cadet, Sebastien
Adamson, Philip D
Moss, Alastair J
Alam, Shirjel
Hunter, Amanda
Shah, Anoop SV
Mills, Nicholas L
Pawade, Tania
Wang, Chengjia
McCall, Jonathan Weir
Roditi, Giles
Beek, Edwin JR van
Nicol, Edward D
Berman, Daniel
Slomka, Piotr J
Dweck, Marc R
Dey, Damini
Newby, David E
Williams, Michelle C - Abstract:
- Abstract : Introduction: This post-hoc analysis of the SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) assessed the frequency and implications of coronary artery disease (CAD) in patients with a zero coronary artery calcium score (CACS). Methods: Agatston CACS was assessed on non-contrast and CAD on contrast CT coronary angiography. Adverse plaque characteristics (APC) were visually identified as positive remodelling or low attenuation plaque and quantitative plaque burden was measured. Results: Of 642 patients with zero CACS, CAD was present in 105 (16%). Compared to patients with normal coronary arteries, those with zero CACS and CAD were older (55±9 vs 53±10 years, p=0.016) and had higher cardiovascular risk scores (14±9 vs 12±8, p=0.013). On CTCA 92 (14%) had non-obstructive CAD, 13 (2%) obstructive CAD, 14 (2%) APC and 85 (13%) low attenuation plaque burden >4%. Compared to patients with normal coronary arteries, those with zero CACS and CAD were more likely to receive statins (67% vs 17%, p<0.001), antiplatelet therapy (74% vs 28%, p<0.001), angiography (18% vs 2%, p<0.001) and revascularisation (7% vs 0%, p<0.001). Quality-of-life and symptoms were similar in patients with normal coronary arteries and those with zero CACS and CAD (p>0.05). Over 5 years of follow-up, 1 event (1%, myocardial infarction) occurred in patients with zero CACS and CAD compared to 3 events (1%, 2 myocardial infarction and 1 coronary heart disease death) in patients with normalAbstract : Introduction: This post-hoc analysis of the SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) assessed the frequency and implications of coronary artery disease (CAD) in patients with a zero coronary artery calcium score (CACS). Methods: Agatston CACS was assessed on non-contrast and CAD on contrast CT coronary angiography. Adverse plaque characteristics (APC) were visually identified as positive remodelling or low attenuation plaque and quantitative plaque burden was measured. Results: Of 642 patients with zero CACS, CAD was present in 105 (16%). Compared to patients with normal coronary arteries, those with zero CACS and CAD were older (55±9 vs 53±10 years, p=0.016) and had higher cardiovascular risk scores (14±9 vs 12±8, p=0.013). On CTCA 92 (14%) had non-obstructive CAD, 13 (2%) obstructive CAD, 14 (2%) APC and 85 (13%) low attenuation plaque burden >4%. Compared to patients with normal coronary arteries, those with zero CACS and CAD were more likely to receive statins (67% vs 17%, p<0.001), antiplatelet therapy (74% vs 28%, p<0.001), angiography (18% vs 2%, p<0.001) and revascularisation (7% vs 0%, p<0.001). Quality-of-life and symptoms were similar in patients with normal coronary arteries and those with zero CACS and CAD (p>0.05). Over 5 years of follow-up, 1 event (1%, myocardial infarction) occurred in patients with zero CACS and CAD compared to 3 events (1%, 2 myocardial infarction and 1 coronary heart disease death) in patients with normal coronary arteries. Conclusion: CAD occurs in 16% of patients with zero CACS, with prognostically significant plaque subtypes occurring in some patients, although the overall event-rate is low. … (more)
- Is Part Of:
- Heart. Volume 106(2020)Supplement 3
- Journal:
- Heart
- Issue:
- Volume 106(2020)Supplement 3
- Issue Display:
- Volume 106, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 106
- Issue:
- 3
- Issue Sort Value:
- 2020-0106-0003-0000
- Page Start:
- A1
- Page End:
- A1
- Publication Date:
- 2020-09-07
- Subjects:
- Heart -- Diseases -- Treatment -- Periodicals
Cardiology -- Periodicals
616.12 - Journal URLs:
- http://www.bmj.com/archive ↗
http://heart.bmj.com ↗
http://www.heartjnl.com ↗ - DOI:
- 10.1136/heartjnl-2020-BSCI.1 ↗
- Languages:
- English
- ISSNs:
- 1355-6037
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18540.xml